118
Participants
Start Date
April 5, 2023
Primary Completion Date
February 20, 2026
Study Completion Date
May 12, 2028
Isatuximab
Investigational medicinal product; Pharmaceutical form: Solution for Subcutaneous administration; Route of administration: Subcutaneous
Carfilzomib
Investigational medicinal product; Pharmaceutical form: Powder for solution for infusion; Route of administration: Intravenous
Dexamethasone
Investigational medicinal product/background treatment; ATC code: H02AB02; Pharmaceutical form: Tablet; Route of administration: Oral
Dexamethasone IV
Investigational medicinal product/background treatment; ATC code: H02AB02; Pharmaceutical form: Powder for solution for infusion; Route of administration: Intravenous
Montelukast
Background Treatment; ATC code: R03DC03; Pharmaceutical form: As per local commercial product; Route of administration: Oral
Acetaminophen
Background Treatment; ATC code: N02BE01; Pharmaceutical form: As per local commercial product; Route of administration: Oral or intravenous (IV)
Diphenhydramine
Background Treatment; ATC code: R06AA02; Pharmaceutical form: As per local commercial product; Route of administration: Oral or IV
Methylprednisolone
Background Treatment/Rescue medication; ATC code: H02AB04; Pharmaceutical form: As per local commercial product; Route of administration: IV
ACTIVE_NOT_RECRUITING
Investigational Site Number : 0360002, Wollongong
ACTIVE_NOT_RECRUITING
Investigational Site Number : 0360001, Fitzroy
RECRUITING
Investigational Site Number : 3000001, Athens
RECRUITING
Investigational Site Number : 3000002, Athens
RECRUITING
Investigational Site Number : 2030001, Prague
RECRUITING
Investigational Site Number : 2030002, Brno
RECRUITING
Investigational Site Number : 2030003, Ostrava - Poruba
RECRUITING
Investigational Site Number : 2030004, Olomouc
RECRUITING
Investigational Site Number : 1560004, Shenyang
RECRUITING
Investigational Site Number : 1560001, Tianjin
RECRUITING
Investigational Site Number : 1560007, Tianjin
RECRUITING
Investigational Site Number : 1560005, Nanchang
RECRUITING
Investigational Site Number : 1560006, Changsha
RECRUITING
Investigational Site Number : 1560003, Wuhan
RECRUITING
Investigational Site Number : 1560002, Guangzhou
RECRUITING
Hospital Mae de Deus Site Number : 0760002, Porto Alegre
RECRUITING
Clinica Sao Germano- Site Number : 0760003, São Paulo
RECRUITING
Hospital das Clinicas de Sao Paulo- Site Number : 0760001, São Paulo
ACTIVE_NOT_RECRUITING
Investigational Site Number : 3920001, Kashiwa-shi
ACTIVE_NOT_RECRUITING
Investigational Site Number : 3920002, Okayama
ACTIVE_NOT_RECRUITING
Investigational Site Number : 6200001, Braga
ACTIVE_NOT_RECRUITING
Investigational Site Number : 6200004, Lisbon
ACTIVE_NOT_RECRUITING
Investigational Site Number : 6200005, Lisbon
Lead Sponsor
Sanofi
INDUSTRY